NYSEMaterialsChemicals - SpecialtySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for NEU yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Enhance cash from operations to at least $124 million | Cash from operations improved to $124 million in Q1 2026. | Intact | cash from operations falls below $120 million next year | Cash from operations: $68.556M FY2026-Q3; GAAP. Published target: >= $124 million. Target period is not explicitly aligned with this observation. Oct 29, 202668,556,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
NEU is a materials business with a value-oriented profile, rather than a high-growth story. Its long-term thesis is intact, but current evidence on management execution is mixed and confidence in the overall assessment is medium.
The valuation evidence describes NEU as cheap versus peers, with a small expectations gap and no flagged signs of concentrated fragility. This suggests modest expectations are built in, though the evidence does not specify what the market assumes about future growth or earnings.
Recent financial performance is strong, but momentum weakened after the latest earnings release. In the near term, specialty materials results improved year over year, while petroleum additives operating profit was nearly unchanged and shipments were down over the first nine months. Cost control and capacity expansion remain priorities, with progress mixed and new capacity not yet confirmed as online.
The near-term thesis would weaken if NEU cuts guidance on its next call. Over the multi-year view, delivery on specialty materials capacity and better cost and margin outcomes matter, while shipments and network efficiency remain watch points. Sector bellwethers such as LIN, ECL, and SHW are useful signals: continued strong results support the sector tailwind, while weaker results could remove it.
For the next one to three years, NEU’s long-term thesis remains intact, with strong recent performance and cheap valuation versus peers balanced by weaker momentum and mixed execution evidence. The key questions are whether guidance holds, capacity plans translate into results, and the sector tailwind persists. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| NewMarket keeps paying and slightly raising dividends, now $3.00 per share. |
| Intact |
| dividend per share falls below $3.00 next year |
Dividend per share: $3.00 per share FY2026-Q3; GAAP. Published target: >= $3.00 per share. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Oct 29, 20263 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Sustain operating income near $143 million | A primary condition in NewMarket Corporation's published investment case. The stated target is >= $140 million. | Intact | operating income falls below $140 million next year | Operating income: $142.944M FY2026-Q3; GAAP. Published target: >= $140 million. Target period is not explicitly aligned with this observation. Oct 29, 2026142,944,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.